Medtronic (NYSE: MDT) today announced new data supporting its Aurora and OmniaSecure defibrillation technology offerings.

Researchers at the University of Innsbruck and Schoen Clinic Roseneck report that structured therapeutic climbing sessions ...

This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...

As cancer immunotherapy continues to evolve, the immunosuppressive tumor microenvironment (TME) remains a major barrier to effective treatment. Now ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) announced that new interim safety and efficacy data from the company’s MyPEAK™-1 Phase 1b/2a clinical trial of TN-201 were presented today during the ...

An innovative online yoga class is being trialled for children with autism, with researchers hoping to find a cost-effective ...

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

Jefferies London Healthcare Conference 2025 November 19, 2025 9:00 AM ESTCompany ParticipantsJohn Quisel - CEO, President ...

With repeated use, the brain becomes accustomed to this artificial inhibition. That cycle of sleeplessness relieved by pills ...

Leading Dubai-based physician believes the future of medicine lies in prevention and treating the human being as a whole ...

Introduction Ascertaining the cause of sudden death is often difficult, even in patients with a history of heart disease.